Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3UUO

The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 17-ID
Synchrotron siteAPS
Beamline17-ID
Temperature [K]95
Detector technologyCCD
Collection date2007-07-02
DetectorADSC QUANTUM 210
Wavelength(s)0.97770
Spacegroup nameP 21 21 21
Unit cell lengths50.566, 82.231, 161.340
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution29.790 - 2.110
R-factor0.1965
Rwork0.195
R-free0.22670
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.009
RMSD bond angle0.940
Data reduction softwareHKL-2000
Data scaling softwareSCALEPACK
Refinement softwareBUSTER (2.11.2)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]30.0002.180
High resolution limit [Å]2.1002.100
Rmerge0.077
Number of reflections37616
Completeness [%]94.473.3
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP7.4291100MM HEPES, 16% PEG 3350, 25 MM MGCL2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon